Victor Shi Selected Research

Victor Shi Research Topics

Disease

37	Heart Failure 01/2022 - 10/2012
9	Hypertension (High Blood Pressure) 10/2011 - 01/2007
4	Hypotension (Low Blood Pressure) 11/2021 - 04/2010
4	Isolated Systolic Hypertension 04/2010 - 01/2007
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 04/2010
3	Hyperkalemia 11/2021 - 01/2017
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 10/2020 - 12/2008
3	Diabetes Mellitus 02/2016 - 01/2008
2	Heart Diseases (Heart Disease) 11/2021 - 01/2020
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 01/2021
2	Cardiomyopathies (Cardiomyopathy) 10/2020 - 01/2020
2	Angioedema 01/2018 - 01/2017
2	Stroke (Strokes) 12/2008 - 01/2007
1	Atrial Fibrillation 01/2022
1	Sudden Death 12/2021
1	Albuminuria 11/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2019
1	Confusion (Bewilderment) 01/2019
1	Cough 01/2017
1	Human Influenza (Influenza) 02/2016
1	Left Ventricular Dysfunction 02/2015
1	Headache (Headaches) 05/2011
1	Dizziness (Lightheadedness) 04/2010
1	Chronic Renal Insufficiency 04/2010
1	Myocardial Infarction 12/2008
1	Proteinuria 01/2008
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2008
1	Edema (Dropsy) 03/2007
1	Acute Coronary Syndrome 01/2007
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 07/2004

Drug/Important Bio-Agent (IBA)

35	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 10/2012
19	Neprilysin (Neutral Endopeptidase)IBA 01/2022 - 10/2012
13	Angiotensin Receptors (Angiotensin II Receptor)IBA 12/2021 - 10/2012
12	Valsartan (Vals)FDA Link 01/2022 - 08/2008
11	Enalapril FDA LinkGeneric 01/2022 - 08/2015
9	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 02/2015
7	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 06/2014
6	Angiotensin Receptor AntagonistsIBA 12/2021 - 08/2008
6	pro-brain natriuretic peptide (1-76)IBA 11/2021 - 10/2012
5	paragonIBA 01/2022 - 01/2020
4	benazepril (Briem)FDA LinkGeneric 04/2010 - 03/2007
4	Amlodipine (Norvasc)FDA LinkGeneric 04/2010 - 03/2007
3	AngiotensinsIBA 01/2022 - 01/2020
3	Antihypertensive Agents (Antihypertensives)IBA 04/2010 - 01/2008
3	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 04/2010 - 01/2008
2	Natriuretic PeptidesIBA 01/2022 - 01/2020
2	Trinitrotoluene (TNT)IBA 01/2021 - 11/2014
2	CreatinineIBA 01/2021 - 04/2010
2	Troponin T (Troponin T1)IBA 01/2021 - 11/2014
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 10/2018 - 01/2016
1	ReninIBA 01/2021
1	Therapeutic UsesIBA 01/2020
1	DiureticsIBA 01/2019
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2019
1	Mineralocorticoid Receptor AntagonistsIBA 01/2017
1	PotassiumIBA 01/2017
1	Influenza Vaccines (Influenza Vaccine)FDA Link 02/2016
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2016
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2016
1	Galectin 3 (LGALS3)IBA 01/2016
1	CollagenIBA 01/2016
1	candesartanIBA 02/2015
1	TroponinIBA 11/2014
1	Drug CombinationsIBA 04/2010
1	ThiazidesIBA 01/2008
1	Glucose (Dextrose)FDA LinkGeneric 01/2008
1	HDL CholesterolIBA 01/2008
1	Triglycerides (Triacylglycerol)IBA 01/2008
1	TabletsIBA 01/2007

Therapy/Procedure

16	Therapeutics 11/2021 - 01/2007
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 10/2020
1	Drug Tapering 01/2019
1	Defibrillators (Defibrillator) 02/2016
1	Patient Readmission 01/2016
1	Investigational Therapies (Experimental Therapy) 02/2015
1	Resuscitation 12/2008
1	Combination Drug Therapy (Combination Chemotherapy) 12/2008
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2007
1	Percutaneous Coronary Intervention 01/2007
1	Cholecystectomy 07/2004